QP Release – expectations and responsibilities for clinical and commercial drug products in Europe

Understanding regulatory legislation is vital for successfully navigating the complex global clinical trials market and ensuring the timely supply of your Investigational Medicinal Products (IMPs). For pharmaceutical companies based outside of Europe it is important to understand European GMP requirements and the role and responsibilities of the QP. How do you ensure that the QP certification is swift and efficient so that you can get your novel or well-established medicine to market?

Listen to our on-demand webinar with industry experts Harry Berlanga and Alessandro Barbato

Additional Resources